Adicet Bio is a startup based in the United States, most recent round Series B, 4 tracked investors.
Based in the United States, Adicet Bio is a startup. Its most recent tracked round is Series B. Brouky records 4 investors associated with the company.
Adicet Bio is a clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.